|
|
|||||||||||
Department of Psychiatry, Bioethics Program, and Center for Behavioral and Decision Sciences in Medicine, University of Michigan, Ann Arbor, Michigan
Department of Psychiatry, Columbia University, New York
Department of Psychiatry, University of Rochester, Rochester, New York
Department of Psychiatry, University of North Carolina, Chapel Hill, North Carolina
Department of Psychiatry, Duke University, Durham, North Carolina
Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
Department of Psychiatry, University of California San Diego and VA San Diego Healthcare System, San Diego, California
Department of Psychiatry, University of Rochester, Rochester, New York, USA
Correspondence: Dr Scott Y. H. Kim, 300 North Ingalls, Ann Arbor, MI 48109-0429, USA. Email: scottkim{at}umich.edu
Declaration of interest D.C.G. is on the advisory boards of several pharmaceutical companies. Funding detailed in Acknowledgements.
Background Although people with schizophrenia display impaired abilities for consent, it is not known how much impairment constitutes incapacity.
Aims To assess a method for determining the categorical capacity status of potential participants in schizophrenia research.
Method Expert-judgement validation of capacity thresholds on the sub-scales of the MacArthur Competence Assessment Tool - Clinical Research (MacCATCR) was evaluated using receiver operating characteristic (ROC) analysis in 91 people with severe mental illness and 40 controls.
Results The ROC areas under the curve for the understanding, appreciation and reasoning sub-scales of the MacCATCR were 0.94 (95% CI 0.880.99), 0.85 (95% CI 0.760.94) and 0.80 (95% CI 0.700.90). These findings yielded negative and positive predictive values of incapacity that can guide the practice of investigators and research ethics committees.
Conclusions By performing such validation studies for a few categories of research with varying risks and benefits, it might be possible to create evidence-based capacity determination guidelines for most schizophrenia research.
This article has been cited by other articles:
![]() |
J. Karlawish, S. Y. H. Kim, D. Knopman, C. H. van Dyck, B. D. James, and D. Marson Interpreting the Clinical Significance of Capacity Scores for Informed Consent in Alzheimer Disease Clinical Trials Am J Geriatr Psychiatry, July 1, 2008; 16(7): 568 - 574. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Appelbaum Assessment of Patients' Competence to Consent to Treatment N. Engl. J. Med., November 1, 2007; 357(18): 1834 - 1840. [Full Text] [PDF] |
||||
![]() |
Bibliography for Ethics, Professionalism, and End of Life Care Focus, January 1, 2007; 5(4): 417 - 419. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |